WHY NEOADJUVANT ANDROGEN DEPRIVATION PRIOR TO RADICAL PROSTATECTOMY IS UNNECESSARY
Data up to Jan 2025
Total Citations Per Year
Abstract
References (109)
Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate
1987 • 2,447 citations
Results of Conservative Management of Clinically Localized Prostate Cancer
1994 • 962 citations
Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. II. Radical Prostatectomy Treated Patients
1989 • 877 citations
Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer
1993 • 805 citations
Important Advances in Oncology
1991 • 768 citations
Correlation of pathologic findings with progression after radical retropubic prostatectomy
1993 • 760 citations
Cancer Control and Quality of Life Following Anatomical Radical Retropubic Prostatectomy: Results at 10 Years
1994 • 704 citations
Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate Cancer
1994 • 703 citations
Prostate Specific Antigen in the Staging of Localized Prostate Cancer: Influence of Tumor Differentiation, Tumor Volume and Benign Hyperplasia
1990 • 625 citations
Prognostic Significance of Positive Surgical Margins in Radical Prostatectomy Specimens
1995 • 565 citations
A Decision Analysis of Alternative Treatment Strategies for Clinically Localized Prostate Cancer
1993 • 563 citations
Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years.
1993 • 563 citations
5-Year Tumor Recurrence Rates After Anatomical Radical Retropubic Prostatectomy For Prostate Cancer
1994 • 539 citations
Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation.
1990 • 485 citations
SERUM PSA AFTER ANATOMIC RADICAL PROSTATECTOMY
1993 • 463 citations
The Incidence and Significance of Detectable Levels of Serum Prostate Specific Antigen After Radical Prostatectomy
1994 • 426 citations
Nerve-Sparing Radical Prostatectomy: Evaluation of Results after 250 Patients
1990 • 411 citations
Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a medicare survey
1995 • 351 citations
Is Tumor Volume an Independent Predictor of Progression Following Radical Prostatectomy? A Multivariate Analysis of 185 Clinical Stage B Adenocarcinomas of the Prostate with 5 Years of Followup
1993 • 347 citations
The Role of Perineural Space Invasion in the Local Spread of Prostatic Adenocarcinoma
1989 • 344 citations
Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma.
1990 • 314 citations
Randomized Prospective Study Comparing Radical Prostatectomy Alone Versus Radical Prostatectomy Preceded by Androgen Blockage in Clinical Stage B2 (T2bNxM0) Prostate Cancer
1995 • 310 citations
Positive Surgical Margins at Radical Prostatectomy: Importance of the Apical Dissection
1990 • 293 citations
Important advances in oncology 1994
1994 • 282 citations
Radical Prostatectomy for Clinical Stage T1-2N0M0 Prostatic Adenocarcinoma: Long-Term Results
1990 • 274 citations
Frequency and Location of Extracapsular Extensionand Positive Surgical Margins in Radical Prostatectomy Specimens
1992 • 260 citations
Impact of Radical Prostatectomy in the Management of Clinically Localized Disease
1994 • 241 citations
Prostate Specific Antigen Levels After Radical Prostatectomy in Patients with Organ Confined and Locally Extensive Prostate Cancer
1992 • 232 citations
Analysis of Risk Factors Associated with Prostate Cancer Extension to the Surgical Margin and Pelvic Node Metastasis at Radical Prostatectomy
1993 • 231 citations
Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors.
1992 • 228 citations
The Mechanisms and Prognostic Significance of Seminal Vesicle Involvement by Prostate Cancer
1993 • 228 citations
Quality of Life: Radical Prostatectomy Versus Radiation Therapy for Prostate Cancer
1995 • 226 citations
Estrogens in the Treatment of Prostate Cancer
1995 • 190 citations
Biochemical and Pathological Effects of 8 Months of Neoadjuvant Androgen Withdrawal Therapy Before Radical Prostatectomy in Patients with Clinically Confined Prostate Cancer
1996 • 162 citations
Pathologic changes associated with androgen deprivation therapy for prostate cancer
1991 • 161 citations
Neoadjuvant Hormonal Therapy Before Radical Prostatectomy Decreases the Number of Positive Surgical Margins in Stage T2 Prostate Cancer: Interim Results of a Prospective Randomized Trial
1995 • 158 citations
Total Prostatectomy for Clinically Localized Prostatic Cancer: Long-term Results
1989 • 148 citations
Recent results of management of palpable clinically localized prostate cancer
1993 • 143 citations
Clinical and Pathobiological Effects of Neoadjuvant Total Androgen Ablation Therapy on Clinically Localized Prostatic Adenocarcinoma
1994 • 134 citations
A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team
1993 • 133 citations
Effect of Combination Endocrine Therapy (LHRH Agonist and Flutamide) on Normal Prostate and Prostatic Adenocarcinoma
1991 • 129 citations
Treatment Related Sequelae Following External Beam Radiation for Prostate Cancer: A Review With an Update in Patients with Stages T1 And T2 Tumor
1994 • 127 citations
Prostate Specific Antigen in Hormonally Treated Stage D2 Prostate Cancer: Is it always an Accurate Indicator of Disease Status?
1991 • 124 citations
Long-term evaluation of radical prostatectomy as treatment for clinical stage C (T3) prostate cancer
1993 • 124 citations
Control of Prostate Cancer with Radiotherapy: Long-Term Results
1994 • 117 citations
Combined Hormone Control Therapy and Radical Prostatectomy in the Treatment of Selected Cases of Advanced Carcinoma of the Prostate: A Retrospective Study Based Upon 25 Years of Experience
1969 • 111 citations
Downstaging of localized prostate cancer by neoadjuvant therapy with flutamide and lupron: the first controlled and randomized trial.
1993 • 111 citations
A Critique of the Decision Analysis for Clinically Localized Prostate Cancer
1994 • 108 citations
Preoperative Androgen Deprivation Therapy: Artificial Lowering of Serum Prostate Specific Antigen without Downstaging the Tumor
1993 • 107 citations
Usefulness of immunoperoxidase staining with high-molecular-weight cytokeratin in the differential diagnosis of small-acinar lesions of the prostate gland
1990 • 104 citations
Resection Margin Status in Radical Retropubic Prostatectomy Specimens: Relationship to Type of Operation, Tumor Size, Tumor Grade and Local Tumor Extension
1990 • 103 citations
Science behind total androgen blockade: from gene to combination therapy.
1993 • 100 citations
Radical retropubic prostatectomy with reduced morbidity: an anatomic approach.
1988 • 98 citations
Prostate Specific Antigen Values after Radical Retropubic Prostatectomy for Adenocarcinoma of the Prostate: Impact of Adjuvant Treatment (Hormonal and Radiation)
1991 • 96 citations
Neoadjuvant Hormonal Deprivation in Patients with Locally Advanced Prostate Cancer
1993 • 90 citations
The role of neoadjuvant hormonal manipulation in localized prostatic cancer
1993 • 88 citations
Histologic changes in prostate carcinomas treated with leuprolide (luteinizing hormone–-releasing hormone effect). Distinction from poor tumor differentiation
1994 • 85 citations
Prostate Specific Antigen as an Outcome Variable for T1 and T2 Prostate Cancer Treated by Radiation Therapy
1994 • 78 citations
Expectant Management of Early Stage Prostatic Cancer: Swedish Experience
1994 • 77 citations
Practice Trends in the Diagnosis and Management of Prostate Cancer in the United States
1995 • 62 citations
Early Prostate Cancer: The National Results of Radiation Treatment from the Patterns of Care and Radiation Therapy Oncology Group Studies With Prospects for Improvement with Conformal Radiation and Adjuvant Androgen Deprivation
1994 • 57 citations
Nerve-Sparing Radical Retropubic Prostatectomy
1985 • 55 citations
Morphologic and lmmunohistochemical changes in prostate cancer after preoperative hormonal therapy. A comparative study of radical prostatectomies
1994 • 55 citations
Surgical Treatment of Locally Advanced (T3) Prostatic Carcinoma: Early Results
1987 • 54 citations
Neoadjuvant Hormonal Deprivation before Radical Prostatectomy
1993 • 54 citations
Prostate-Specific Antigen Testing in Untreated and Treated Prostatic Adenocarcinoma
1990 • 50 citations
Histopathological Changes in Androgen-Deprived Localized Prostatic Cancer
1993 • 50 citations
High failure rate associated with long‐term follow‐up of neoadjuvant androgen deprivation followed by radical prostatectomy for stage C prostatic cancer
1995 • 47 citations
ENDOCRINE THERAPY IN CARCINOMA OF THE PROSTATE
1947 • 47 citations
Surgical management of prostate cancer. Contemporary results with anatomic radical prostatectomy
1995 • 46 citations
Expectant Management of Clinically Localized Prostatic Cancer
1994 • 46 citations
Use of neoadjuvant androgen deprivation therapy in clinically localized prostate cancer.
1993 • 43 citations
Surgical management of prostate cancer. Contemporary results with anatomic radical prostatectomy
1995 • 42 citations
Neoadjuvant androgen blockade prior to prostatectomy: A retrospective study and critical review
1994 • 41 citations
Early stage prostate cancer: diagnosis and choice of therapy
1989 • 37 citations
Transrectal ultrasound evaluation of local prostate cancer in patients treated with LHRH agonist and in combination with flutamide
1992 • 36 citations
Androgen deprivation prior to radical prostatectomy for T2b and T3 prostate cancer
1994 • 33 citations
Complete Androgen Deprivation prior to Radical Prostatectomy in Patients with Stage T(3) Cancer of the Prostate
1991 • 33 citations
Luteinizing Hormone-Releasing Hormone Downstaging of Clinical Stage C Prostate Cancer
1992 • 32 citations
Hormone ablation therapy as neoadjuvant treatment to radical prostatectomy.
1993 • 30 citations
An Evaluation of Endocrine Therapy Plus Radical Perineal Prostatectomy in the Treatment of Advanced Carcinoma of the Prostate
1964 • 30 citations
Downstaging by combination therapy with flutamide and an LHRH agonist before radical prostatectomy.
1995 • 29 citations
New horizons in the surgical management of carcinoma of the prostate gland
1949 • 28 citations
Neoadjuvant Hormonal Deprivation before Radical Prostatectomy
1993 • 27 citations
Neoadjuvant GnRH-Agonist Treatment (Triptorelin and Cyproterone Acetate for Flare Protection) and Total Prostatectomy
1993 • 24 citations
Neoadjuvant hormonal therapy in stage C adenocarcinoma of the prostate.
1993 • 23 citations
Treatment of early stage prostate cancer: radical prostatectomy.
1994 • 21 citations
Neoadjuvant hormonal therapy and radical prostatectomy for clinical stage C carcinoma of the prostate
1994 • 21 citations
A Multicentre Trial of Combined Neoadjuvant Androgen Blockade with Zoladex and Flutamide prior to Radical Prostatectomy in Prostate Cancer
1994 • 20 citations
Combination of screening and preoperative endocrine therapy: the potential for an important decrease in prostate cancer mortality.
1995 • 20 citations
Hormone control therapy as a preparation for radical perineal prostatectomy in advanced carcinoma of the prostate.
1949 • 19 citations
The Effects of Treatment on the Local Lesion of Carcinoma of the Prostate
1973 • 19 citations
ENDOCRINE THERAPY IN CARCINOMA OF THE PROSTATE
1955 • 18 citations
THE ROLE OF ENDOCRINE THERAPY IN THE MANAGEMENT OF LOCAL AND DISTANT RECURRENCE OF PROSTATE CANCER FOLLOWING RADICAL PROSTATECTOMY OR RADIATION THERAPY
1994 • 18 citations
Hormonal pretreatment does not affect the final pathologic stage in locally advanced prostate cancer
1994 • 18 citations
Significance of androgen deprivation prior to radical prostatectomy, with special reference to prostate-specific antigen
1993 • 15 citations
Downstaging of Stage C Prostatic Carcinoma by Inductive Chemo-Hormonal Therapy?
1993 • 14 citations
Non-Resectable Carcinoma of the Prostate Rendered Resectable by Endocrine Therapy
1966 • 14 citations
Combination of screening and preoperative endocrine therapy: the potential for an important decrease in prostate cancer mortality
1995 • 13 citations
Prostatic Carcinoma Cured with Hormonal Treatment
1981 • 12 citations
The role of transrectal ultrasound-guided staging biopsy and androgen ablation therapy prior to radical prostatectomy.
1993 • 11 citations
Is Combined Modality Therapy Appropriate for Apparently Localized Carcinoma of the Prostate?
1991 • 11 citations
Effects of 3 Months' Neoadjuvant Hormonal Treatment with a GnRH Analogue (Triptorelin) prior to Radical Retropubic Prostatectomy on Prostate-Specific Antigen and Tumour Volume in Prostate Cancer
1994 • 10 citations
Endocrine Treatment prior to Radical Retropubic Prostatectomy in Patients with T<sub>3</sub> Prostate Cancer: A Retrospective Study of 22 Patients
1992 • 10 citations
Computer Modeling of Prostate Cancer Treatment
1995 • 10 citations
Neoadjuvant hormonal manipulation: A strategy for chemoprevention trials
1992 • 8 citations
Role of induction androgen deprivation before radical prostatectomy.
1995 • 6 citations
Treatment of early stage prostate cancer: conservative management--delayed therapy.
1994 • 2 citations
Workshop Summary: Hormonal Suppression in Neoadjuvant Setting and Advanced Disease
1993 • 2 citations
Cited By (0)
No citing papers found in database